This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

31 May 2012

Pharmaceutical Companies Allocating More Money to Digital Marketing

A report by Cutting Edge Information has highlighted the growing importance of digital marketing in the pharmaceutical industry.

Pharmaceutical companies are allocating increasingly large amounts of money to digital media for their product launches, research suggests.


The latest report from consulting firm Cutting Edge Information, entitled 'Launching Pharmaceutical Brands: Formulas for Commercialisation Success', found that digital marketing now plays an important role in global launches.


In fact, for the average pharmaceutical brand, investment in digital marketing will soon outstrip budgets for traditional media, the firm claims.


On average, the 15 pharmaceutical brand teams examined by researchers spent $150,000 on digital marketing, per molecule, during phase-IIIa clinical development, and this figure tripled during

Related News